Jan Lillienau

700 total citations
22 papers, 582 citations indexed

About

Jan Lillienau is a scholar working on Oncology, Surgery and Gastroenterology. According to data from OpenAlex, Jan Lillienau has authored 22 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Surgery and 4 papers in Gastroenterology. Recurrent topics in Jan Lillienau's work include Drug Transport and Resistance Mechanisms (14 papers), Pediatric Hepatobiliary Diseases and Treatments (6 papers) and Gastroesophageal reflux and treatments (3 papers). Jan Lillienau is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pediatric Hepatobiliary Diseases and Treatments (6 papers) and Gastroesophageal reflux and treatments (3 papers). Jan Lillienau collaborates with scholars based in Sweden, United States and Russia. Jan Lillienau's co-authors include Alan F. Hofmann, Huong‐Thu Ton‐Nu, Kim E. Barrett, Claudio D. Schteingart, C D Schteingart, Erik Hertervig, Diane L. Crombie, Aijaz Farooqi, Truls Hauge and Berit Sternby and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and Hepatology.

In The Last Decade

Jan Lillienau

21 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Lillienau Sweden 12 282 247 132 92 90 22 582
N. Tanaka Japan 15 292 1.0× 203 0.8× 155 1.2× 86 0.9× 84 0.9× 26 723
Hofmann Af United States 12 368 1.3× 282 1.1× 61 0.5× 68 0.7× 121 1.3× 25 647
S Kuroki Japan 15 255 0.9× 301 1.2× 104 0.8× 50 0.5× 83 0.9× 35 596
Florence Y. Lee United States 7 384 1.4× 247 1.0× 221 1.7× 45 0.5× 163 1.8× 8 616
D Panveliwalla United Kingdom 7 224 0.8× 92 0.4× 80 0.6× 44 0.5× 139 1.5× 12 407
Y Muto Japan 14 77 0.3× 100 0.4× 432 3.3× 31 0.3× 211 2.3× 34 819
Mariska Geuken Netherlands 11 564 2.0× 303 1.2× 214 1.6× 137 1.5× 207 2.3× 14 806
Elena Bellafante Italy 9 208 0.7× 188 0.8× 214 1.6× 34 0.4× 269 3.0× 14 608
M. Otte Germany 13 95 0.3× 230 0.9× 46 0.3× 18 0.2× 135 1.5× 30 566
Wei‐Chih Su Taiwan 15 370 1.3× 272 1.1× 197 1.5× 14 0.2× 32 0.4× 79 790

Countries citing papers authored by Jan Lillienau

Since Specialization
Citations

This map shows the geographic impact of Jan Lillienau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lillienau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lillienau more than expected).

Fields of papers citing papers by Jan Lillienau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Lillienau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lillienau. The network helps show where Jan Lillienau may publish in the future.

Co-authorship network of co-authors of Jan Lillienau

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Lillienau. A scholar is included among the top collaborators of Jan Lillienau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Lillienau. Jan Lillienau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lillienau, Jan, et al.. (2025). Teduglutide treatment during breast feeding in a patient with intestinal failure: a case report. Frontiers in Nutrition. 12. 1567908–1567908.
2.
Cremers, Isabelle, et al.. (2020). European Specialty Examination in Gastroenterology and Hepatology examination — improving education in gastroenterology and hepatology. World Journal of Meta-Analysis. 8(2). 41–47. 3 indexed citations
3.
Molin, Daniel, et al.. (2018). Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease. Therapeutic Advances in Gastroenterology. 11. 3971990108–3971990108. 26 indexed citations
4.
Tóth, Ervin, Jan Lillienau, Mats Ekelund, et al.. (2006). Ulcerated small-intestine duplication cyst: an unusual source of GI bleeding revealed by wireless capsule endoscopy. Gastrointestinal Endoscopy. 63(1). 192–194. 11 indexed citations
5.
Lillienau, Jan, Yajun Cheng, Åke Nilsson, & Rui‐Dong Duan. (2003). Development of intestinal alkaline sphingomyelinase in rat fetus and newborn rat. Lipids. 38(5). 545–549. 13 indexed citations
6.
Duan, Rong, Erik Hertervig, Truls Hauge, et al.. (1996). Distribution of alkaline sphingomyelinase activity in human beings and animals. Digestive Diseases and Sciences. 41(9). 1801–1806. 86 indexed citations
7.
Lillienau, Jan, et al.. (1993). Negative feedback regulation of the ileal bile acid transport system in rodents. Gastroenterology. 104(1). 38–46. 63 indexed citations
8.
Schmassmann, Adrian, H F Fehr, J. Locher, et al.. (1993). Cholylsarcosine, a new bile acid analogue: Metabolism and effect on biliary secretion in humans. Gastroenterology. 104(4). 1171–1181. 35 indexed citations
9.
Sorscher, Steven, Jan Lillienau, Judy L. Meinkoth, et al.. (1992). Conjugated bile acid uptake by Xenopus laevis oocytes induced by microinjection with ileal poly A+ mRNA. Biochemical and Biophysical Research Communications. 186(3). 1455–1462. 20 indexed citations
10.
Heuman, Douglas M., Z. Reno Vlahčevič, William M. Pandak, et al.. (1992). Effect of cholylsarcosine on hepatic cholesterol and bile acid synthesis and bile secretion in rats. Gastroenterology. 103(5). 1641–1648. 6 indexed citations
11.
Lillienau, Jan, C D Schteingart, & Alan F. Hofmann. (1992). Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine.. Journal of Clinical Investigation. 89(2). 420–431. 45 indexed citations
12.
Lillienau, Jan, et al.. (1992). Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Digestive Diseases and Sciences. 37(8). 1217–1227. 12 indexed citations
13.
Hamilton, Ronald L., Diane L. Crombie, Claudio D. Schteingart, et al.. (1992). Acute Effects of Topical Methyl Tert–Butyl Ether or Ethyl Propionate on Gallbladder Histology in Animals: A Comparison of Two Solvents for Contact Dissolution of Cholesterol Gallstones. Hepatology. 16(4). 984–991. 11 indexed citations
14.
Steinbach, Joseph H., Huong‐Thu Ton‐Nu, Jan Lillienau, et al.. (1991). Active absorption of conjugated bile acids in vivo. Gastroenterology. 100(1). 212–221. 50 indexed citations
15.
Hofmann, Alan F., Claudio D. Schteingart, & Jan Lillienau. (1991). Biological and Medical Aspects of Active Heal Transport of Bile Acids. Annals of Medicine. 23(2). 169–175. 23 indexed citations
16.
Lillienau, Jan, Lee R. Hagey, & Bengt Borgström. (1991). Hepatic and ileal transport and effect on biliary secretion of norursocholic acid and its conjugates in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 261(6). G1057–G1064. 2 indexed citations
17.
Ton‐Nu, Huong‐Thu, et al.. (1991). Activation of mast cells by bile acids. Gastroenterology. 101(2). 446–456. 137 indexed citations
18.
Andersson, Richard, K.‐G. Tranberg, Jan Lillienau, et al.. (1990). Influence of Individual Bile Acids inEscherichia coliPeritonitis. Scandinavian Journal of Gastroenterology. 25(11). 1129–1136. 6 indexed citations
19.
Borgström, Bengt, et al.. (1987). Deconjligation of bile salts: Does it occur outside the contents of the intestinal tract in the rat?. Scandinavian Journal of Clinical and Laboratory Investigation. 47(6). 543–549. 6 indexed citations
20.
Borgström, Bengt, et al.. (1986). Effects of feeding ursocholic acid to germfree rats. Scandinavian Journal of Clinical and Laboratory Investigation. 46(2). 183–187. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Tanaka Breakdown of academic impact, for papers by Hofmann Af Breakdown of academic impact, for papers by S Kuroki Breakdown of academic impact, for papers by Florence Y. Lee Breakdown of academic impact, for papers by D Panveliwalla Breakdown of academic impact, for papers by Y Muto Breakdown of academic impact, for papers by Mariska Geuken Breakdown of academic impact, for papers by Elena Bellafante Breakdown of academic impact, for papers by M. Otte Breakdown of academic impact, for papers by Wei‐Chih Su
Rankless by CCL
2026